SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-040482
Filing Date
2020-12-02
Accepted
2020-12-02 16:02:53
Documents
8
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea130854-6k_therapixbio.htm 6-K 20481
2 NOTICE AND PROXY STATEMENT FOR THE SPECIAL GENERAL MEETING TO BE HELD ON JANUARY ea130854ex99-1_therapixbio.htm EX-99.1 52847
3 PROXY CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON JANUARY 6, 2021 ea130854ex99-2_therapixbio.htm EX-99.2 16477
4 VOTING INSTRUCTION CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON JANUARY 6, ea130854ex99-3_therapixbio.htm EX-99.3 2084
5 GRAPHIC ex99-1_001.jpg GRAPHIC 3604
6 GRAPHIC ex99-2_001.jpg GRAPHIC 10453
7 GRAPHIC ex99-3_001.jpg GRAPHIC 271145
8 GRAPHIC ex99-3_002.jpg GRAPHIC 206663
  Complete submission text file 0001213900-20-040482.txt   770454
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201363767
SIC: 2834 Pharmaceutical Preparations